Morgan Stanley lowered the firm’s price target on Goldman Sachs (GS) to $659 from $782 and keeps an Overweight rating on the shares. The robust ...

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target hoisted by equities researchers at Morgan Stanley from $123.00 to $130.00 in a research note issued to investors on ...

Afya (NASDAQ:AFYA – Get Free Report) was downgraded by investment analysts at Morgan Stanley from an “equal weight” rating to ...

U.S. stocks have suffered their sharpest selloff in months over recent days as investors have grown nervous that President ...

Goldman Sachs has cut its year-end target for the S&P 500 to 6,200 from 6,500, citing a weaker U.S. economic outlook and ...

Hellman & Friedman (H&F) is seeking to raise at least US$1 billion (C$1.4 billion) in equity for Hub International Ltd. in a ...

The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...

Canadian Pacific Kansas City Limited (TSX: CP) (NYSE: CP) ("CPKC") announced that its wholly-owned subsidiary, Canadian ...

Banks have been acknowledging AI-related risks in their annual reports for the past couple years, but new concerns are cropping up as the sector embraces A1.

The big investment banks are increasingly forecasting a poor year for the S&P 500 after a two-year bull run, and say there ...

Let's find out if analysts think that this week's market sell off has created a buying opportunity. The post Are Qantas ...